Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1984 2
1985 1
1986 1
1987 1
1988 2
1989 6
1990 1
1994 1
2002 1
2004 1
2005 1
2006 5
2010 4
2011 2
2012 2
2013 4
2014 2
2015 3
2016 1
2017 1
2019 1
2021 2
2022 3
2023 5
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
[Malakoplakia].
Debré B, Leleu C. Debré B, et al. Among authors: leleu c. Ann Urol (Paris). 1984 Feb;18(1):6-12. Ann Urol (Paris). 1984. PMID: 6529199 French.
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study.
Beyrouti A, Deuze J, Fontas E, Foureau A, Barbarot S, Aubert H, Bernier C, Le Moigne M, Passeron T, Boukari F, Garnier M, Jachiet M, Tetart F, Seneschal J, Toussaint C, Mahé E, Leleu C, Regnault MM, Pasteur J, Nosbaum A, Badaoui A, Fougerousse AC, Pralong P, Viguier M, Droitcourt C, Abasq C, Mallet S, Raison-Peyron N, Staumont-Sallé D, Hubiche T; French Atopic Dermatitis Network (FRADEN) from the Groupe de Recherche sur l’Eczéma Atopique (GREAT) Research Group. Beyrouti A, et al. Among authors: leleu c. J Allergy Clin Immunol Pract. 2025 Feb;13(2):353-360. doi: 10.1016/j.jaip.2024.12.001. Epub 2024 Dec 12. J Allergy Clin Immunol Pract. 2025. PMID: 39672377
Hand eczema in glove-wearing patients.
Clément A, Ferrier le Bouëdec MC, Crépy MN, Raison-Peyron N, Tétart F, Marcant P, Pralong P, Valois A, Pasteur J, Assier H, Bernier C, Le Cam MT, Hacard F, Nosbaum A, Giordano Labadie F, Morice C, Leleu C, Milpied B, Darrigade AS, Delaunay J, Barbaud A, Castelain F, Collet E, Amsler E; from the Dermatology and Allergology group of the French Society of Dermatology (DAG). Clément A, et al. Among authors: leleu c. Contact Dermatitis. 2023 Sep;89(3):143-152. doi: 10.1111/cod.14357. Epub 2023 Jun 18. Contact Dermatitis. 2023. PMID: 37331721
Rheumatological features of Whipple disease.
Tison A, Preuss P, Leleu C, Robin F, Le Pluart A, Vix J, Le Mélédo G, Goupille P, Gervais E, Cormier G, Albert JD, Perdriger A, Bouvard B, Berthelot JM, Foulquier N, Saraux A. Tison A, et al. Among authors: leleu c. Sci Rep. 2021 Jun 10;11(1):12278. doi: 10.1038/s41598-021-91671-9. Sci Rep. 2021. PMID: 34112875 Free PMC article.
Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity.
Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, Puzenat E, Pasteur J, Raison-Peyron N, Giordano-Labadie F, Droitcourt C, Leleu C, Nosbaum A, Aubert H, Moigne MLE, Bernier C, Barbarot S, Ezzedine K, Diaz E, Hubiche T, Faiz S, Azib S, Dezoteux F, Chosidow O, Staumont-Salle D; French Atopic Dermatitis Network from the Group of Research and Study in Atopic Dermatitis (GREAT), the French Society of Dermatology (SFD). Dupuis J, et al. Among authors: leleu c. J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e174-e178. doi: 10.1111/jdv.20264. Epub 2024 Jul 31. J Eur Acad Dermatol Venereol. 2025. PMID: 39082796 No abstract available.
Publisher Correction: Rheumatological features of Whipple disease.
Tison A, Preuss P, Leleu C, Robin F, Le Pluart A, Vix J, Le Mélédo G, Goupille P, Gervais E, Cormier G, Albert JD, Perdriger A, Bouvard B, Berthelot JM, Foulquier N, Saraux A. Tison A, et al. Among authors: leleu c. Sci Rep. 2021 Aug 4;11(1):16197. doi: 10.1038/s41598-021-94889-9. Sci Rep. 2021. PMID: 34349122 Free PMC article. No abstract available.
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort.
Nguyen Y, Baron G, Hamamouche N, Belkhir R, Miconnet S, Soubrier M, Hostachy C, Thevenot P, Basch A, Truchetet ME, Claudepierre P, Dernis E, Marotte H, Flipo RM, Brocq O, Morel J, Fautrel B, Salliot C, Saraux A, Leske C, Schaeverbeke T, Ravaud P, Mariette X, Ruyssen-Witrand A, Seror R; ART Study Group§. Nguyen Y, et al. Rheumatology (Oxford). 2025 May 1;64(5):2496-2504. doi: 10.1093/rheumatology/keae599. Rheumatology (Oxford). 2025. PMID: 39576675 Clinical Trial.
What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).
Amsler E, Assier H, Soria A, Bara C, Ferrier le Bouëdec MC, Barbaud A, Milpied B, Giordano-Labadie F, Pasteur J, Badaoui A, Valois A, Castelain F, Kurihara F, Castagna J, Boulard C, Bernier C, Leleu C, Marcant P, Crépy MN, Tetart F, Raison-Peyron N; from the Dermatology and Allergy Group of the French Society of Dermatology (DAG). Amsler E, et al. Among authors: leleu c. Contact Dermatitis. 2022 Aug;87(2):170-175. doi: 10.1111/cod.14118. Epub 2022 Apr 15. Contact Dermatitis. 2022. PMID: 35383393
57 results